Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Late-Stage Pipeline

25%

2 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06458673Not Yet Recruiting

A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules

Role: collaborator

NCT05892354Not ApplicableRecruiting

Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy

Role: collaborator

NCT05684328Not ApplicableRecruiting

Narrow Band Imaging Versus White Light for the Detection and Miss of Sessile Serrated Lesion

Role: collaborator

NCT05914272Not Yet Recruiting

Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction

Role: collaborator

NCT05845372Not Yet Recruiting

Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy

Role: collaborator

NCT04957862Not ApplicableUnknown

Robotic Assisted Evacuation of Subacute and Chronic Supratentorial Deep Hypertensive Intracerebral Hemorrhage

Role: collaborator

NCT04150835Phase 4Unknown

Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Role: collaborator

NCT03236636Phase 3Unknown

The Phase III Study of Icaritin Versus HUACHANSU PIAN in Hepatocellular Carcinoma Subjects

Role: collaborator

All 8 trials loaded